TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
2.680
+0.160 (6.35%)
At close: May 15, 2026, 4:00 PM EDT
2.690
+0.010 (0.37%)
Pre-market: May 18, 2026, 9:01 AM EDT
TriSalus Life Sciences Market Cap
TriSalus Life Sciences has a market cap or net worth of $164.6 million as of May 18, 2026. Its market cap has decreased by -10.62% in one year.
Market Cap
164.60M
Enterprise Value
142.53M
1-Year Change
-10.62%
Ranking
Category
Stock Price
$2.68
Market Cap Chart
Since February 8, 2021, TriSalus Life Sciences's market cap has decreased from $328.75M to $164.60M, a decrease of -49.93%. That is a compound annual growth rate of -12.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 164.60M | -52.80% |
| Dec 31, 2025 | 348.75M | 128.28% |
| Dec 31, 2024 | 152.77M | -31.30% |
| Dec 29, 2023 | 222.38M | -29.05% |
| Dec 30, 2022 | 313.44M | 1.52% |
| Dec 31, 2021 | 308.75M | -6.08% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Quantum-Si incorporated | 193.83M |
| Lucid Diagnostics | 189.07M |
| InfuSystem Holdings | 177.10M |
| Inogen | 172.74M |
| Treace Medical Concepts | 172.56M |
| Apyx Medical | 169.41M |
| Owlet | 160.96M |
| CVRx, Inc. | 158.95M |